Trials / Conditions / Hypersensitivity, Immediate

Hypersensitivity, Immediate

22 registered clinical trials studyying Hypersensitivity, Immediate — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Head-to-Head Comparison Study Between Different FDA Registered Allergy Skin Test Applicators NCT07400718	QHSLab, Inc.	N/A
Recruiting	Risk-stratified Testing for Safe Removal of Penicillin Allergy Labels NCT06755281	Deniz Göcebe	N/A
Not Yet Recruiting	Assessment of Er:YAG Laser for the Control of Hypersensitivity During Tooth Whitening With Hydrogen Peroxide NCT06538129	University of Nove de Julho	N/A
Recruiting	Repertoire and Properties of Anti-drug Antibodies Involved in Immediate Hypersensitivity in the Operating Room NCT05420935	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Norwegian Birch Rust Allergy Study NCT05661812	University Hospital of North Norway	—
Completed	The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge NCT04454229	Austin Health	N/A
Unknown	Tromsø Birch Rust Allergy Study. Allergy to Birch Rust, a Possible Explanation to Seasonal Airway Allergy Duri NCT04322838	University Hospital of North Norway	—
Completed	Clinical Determinants and Perioperative Allergic Reactions (CADECAP Study) NCT03918772	Assistance Publique - Hôpitaux de Paris	—
Completed	Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE) NCT03688074	AstraZeneca	Phase 2
Completed	Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe At NCT03720470	Pfizer	Phase 3
Completed	Effect of Benralizumab in Atopic Dermatitis NCT03563066	McMaster University	Phase 2
Completed	Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Se NCT03627767	Pfizer	Phase 3
Completed	Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Derma NCT03054428	Regeneron Pharmaceuticals	Phase 3
Completed	A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Spec NCT02916888	Yale University	—
Completed	The Significance of Blood-tryptase and c-Kit Mutation in Insect Venom Immunotherapy NCT02503800	Meir Medical Center	—
Completed	Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC) NCT02163122	National Institute of Allergy and Infectious Diseases (NIAID)	EARLY_Phase 1
Completed	Peanut Epicutaneous Phase II Immunotherapy Clinical Trial NCT01904604	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Completed	Asthma Data Innovation Demonstration Project NCT02162576	David Van Sickle	N/A
Completed	A Study to Compare the Effects of Different Sized Particles on Cells in the Nose NCT01257191	University of California, Los Angeles	Phase 1
Completed	Pathogenesis of Physical Induced Urticarial Syndromes NCT00887939	National Institute of Allergy and Infectious Diseases (NIAID)	—
Unknown	Allergy Towards Grass and Bronchial Inflammation - Related to Immunotherapy and Exhaled Nitrogen Oxide NCT00312312	Bispebjerg Hospital	N/A
Completed	Clinical and Immunological Evaluation of Children With Allergies NCT00102570	National Institute of Allergy and Infectious Diseases (NIAID)	—